208 related articles for article (PubMed ID: 28089722)
1. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
[TBL] [Abstract][Full Text] [Related]
2. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
3. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
[TBL] [Abstract][Full Text] [Related]
4. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
Abu-Ghanem Y; Zilberman DE; Dotan Z; Kaver I; Ramon J
Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
[TBL] [Abstract][Full Text] [Related]
5. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
Int J Clin Oncol; 2020 Aug; 25(8):1551-1561. PubMed ID: 32504136
[TBL] [Abstract][Full Text] [Related]
7. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
8. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
Iwata T; Kimura S; Foerster B; Abufaraj M; Karakiewicz PI; Preisser F; Nasu Y; Shariat SF
Urol Oncol; 2019 Apr; 37(4):273-281. PubMed ID: 30737159
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.
Abu-Ghanem Y; Dotan Z; Zilberman DE; Kaver I; Ramon J
Sci Rep; 2019 Feb; 9(1):1160. PubMed ID: 30718860
[TBL] [Abstract][Full Text] [Related]
10. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
Soubra A; Zabell JR; Adejoro O; Konety BR
Clin Genitourin Cancer; 2015 Jun; 13(3):e173-81. PubMed ID: 25600760
[TBL] [Abstract][Full Text] [Related]
11. Perioperative Blood Transfusion Is a Predictor of Acute and Chronic Renal Function Deterioration after Partial and Radical Nephrectomy for Renal Cell Carcinoma.
Mühlbauer J; de Gilde J; Mueller-Steinhardt M; Porubsky S; Walach M; Nuhn P; Klüter H; Wagener N; Kriegmair MC
Urol Int; 2020; 104(9-10):775-780. PubMed ID: 32721964
[TBL] [Abstract][Full Text] [Related]
12. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
[TBL] [Abstract][Full Text] [Related]
13. Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.
Tsivian M; Abern MR; Tsivian E; Sze C; Jibara G; Rampersaud EN; Polascik TJ
Urol Oncol; 2018 Aug; 36(8):362.e1-362.e7. PubMed ID: 29793797
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis.
Xia L; Hu G; Guzzo TJ
Anticancer Res; 2017 Jun; 37(6):3175-3181. PubMed ID: 28551661
[TBL] [Abstract][Full Text] [Related]
15. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
16. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
[TBL] [Abstract][Full Text] [Related]
17. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
Xu J; Bai J; Pan H; Zhou Z
Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.
Abu-Ghanem Y; Dotan Z; Kaver I; Ramon J
J Surg Oncol; 2015 Oct; 112(5):496-502. PubMed ID: 26437866
[TBL] [Abstract][Full Text] [Related]
19. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
20. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
